Boundless Bio, Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.39M | -65.69M | -65.36M | -61.06M | -57.72M |
| Total Depreciation and Amortization | 1.19M | 1.14M | 1.09M | 1.04M | 1.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.73M | 5.98M | 5.11M | 3.79M | 2.63M |
| Change in Net Operating Assets | 1.28M | -1.02M | -1.68M | -732.00K | -1.81M |
| Cash from Operations | -55.19M | -59.60M | -60.84M | -56.96M | -55.89M |
| Capital Expenditure | -1.06M | -2.51M | -2.54M | -2.34M | -2.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.36M | -38.67M | -23.57M | -9.77M | -39.95M |
| Cash from Investing | 38.31M | -41.18M | -26.10M | -12.11M | -41.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 230.00K | 93.11M | 93.17M | 93.10M | 93.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -329.00K | -329.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.00K | -2.37M | -3.35M | -4.44M | -4.96M |
| Cash from Financing | 217.00K | 90.75M | 89.82M | 88.33M | 87.89M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.67M | -10.03M | 2.88M | 19.25M | -9.95M |